TY - JOUR
T1 - Neurotechnological solutions for post-traumatic stress disorder
T2 - A perspective review and concept proposal
AU - Laugharne, Richard
AU - Farid, Mohsen
AU - James, Christopher
AU - Dutta, Anirban
AU - Mould, Christopher
AU - Molten, Noelle
AU - Laugharne, Jonathan
AU - Shankar, Rohit
N1 - Publisher Copyright:
© 2023 The Authors. Healthcare Technology Letters published by John Wiley & Sons Ltd on behalf of The Institution of Engineering and Technology.
PY - 2023/11/28
Y1 - 2023/11/28
N2 - Post-traumatic stress disorder (PTSD) is an anxiety condition caused by exposure to severe trauma. It is characterised by nightmares, flashbacks, hyper-vigilance and avoidance behaviour. These all lead to impaired functioning reducing quality of life. PTSD affects 2–5% of the population globally. Most sufferers cannot access effective treatment, leading to impaired psychological functioning reducing quality of life. Eye movement desensitisation and reprocessing (EMDR) is a non-invasive brain stimulation treatment that has shown significant clinical effectiveness in PTSD. Another treatment modality, that is, trauma-focused cognitive behavioural therapy is also an effective intervention. However, both evidence-based treatments are significantly resource intensive as they need trained therapists to deliver them. A concept of a neuro-digital tool for development is proposed to put to clinical practice of delivering EMDR to improve availability, efficiency and effectiveness of treatment. The evidence in using new technologies to measure sleep, geolocation and conversational analysis of social media to report objective outcome measures is explored. If achieved, this can be fed back to users with data anonymously collated to evaluate and improve the tool. Coproduction would be at the heart of product development so that the tool is acceptable and accessible to people with the condition.
AB - Post-traumatic stress disorder (PTSD) is an anxiety condition caused by exposure to severe trauma. It is characterised by nightmares, flashbacks, hyper-vigilance and avoidance behaviour. These all lead to impaired functioning reducing quality of life. PTSD affects 2–5% of the population globally. Most sufferers cannot access effective treatment, leading to impaired psychological functioning reducing quality of life. Eye movement desensitisation and reprocessing (EMDR) is a non-invasive brain stimulation treatment that has shown significant clinical effectiveness in PTSD. Another treatment modality, that is, trauma-focused cognitive behavioural therapy is also an effective intervention. However, both evidence-based treatments are significantly resource intensive as they need trained therapists to deliver them. A concept of a neuro-digital tool for development is proposed to put to clinical practice of delivering EMDR to improve availability, efficiency and effectiveness of treatment. The evidence in using new technologies to measure sleep, geolocation and conversational analysis of social media to report objective outcome measures is explored. If achieved, this can be fed back to users with data anonymously collated to evaluate and improve the tool. Coproduction would be at the heart of product development so that the tool is acceptable and accessible to people with the condition.
KW - biomedical communication
KW - feedback
KW - health care
KW - learning (artificial intelligence)
KW - patient care
KW - patient rehabilitation
KW - patient treatment
KW - risk analysis
UR - http://www.scopus.com/inward/record.url?scp=85177768143&partnerID=8YFLogxK
UR - https://pearl.plymouth.ac.uk/context/pms-research/article/2145/viewcontent/Healthcare_Tech_Letters___2023___Laugharne___Neurotechnological_solutions_for_post_traumatic_stress_disorder_A_perspective.pdf
U2 - 10.1049/htl2.12055
DO - 10.1049/htl2.12055
M3 - Review article
AN - SCOPUS:85177768143
SN - 2053-3713
VL - 10
SP - 133
EP - 138
JO - Healthcare Technology Letters
JF - Healthcare Technology Letters
IS - 6
ER -